Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

112
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
112
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

249
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
249
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

110
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
110
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

366
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
366
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

214
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
214
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

190
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
190

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating 'k-land': a qualitative exploration of participants' experiences of ketamine-assisted psychotherapy for methamphetamine use disorder.

Frontiers in psychiatry·2026
Same author

A comprehensive overview of paracetamol poisoning admissions and long-term outcomes in New South Wales, Australia: a retrospective linked data cohort (PAVLOVA-3).

The Lancet regional health. Western Pacific·2026
Same author

Ten-Year Public Expenditure Savings Associated with TNF Inhibitor Biosimilars under Australia's Pharmaceutical Benefits Scheme.

Clinical pharmacology and therapeutics·2026
Same author

"Large-Scale and Local Functional Connectivity Changes Following Psilocybin Administration in Methamphetamine Use Disorder.

AJNR. American journal of neuroradiology·2026
Same author

International Trends in Dental Opioid Prescriptions.

JAMA network open·2026
Same author

Unlocking clinical narratives: how natural language processing and artificial intelligence can address data deficits and mitigate health inequities in urgent and emergency care.

Emergency medicine journal : EMJ·2026

Related Experiment Video

Updated: Dec 7, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.2K

A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing:

David W Uster1, Sophie L Stocker2,3, Jane E Carland2,3

  • 1Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Hamburg, Germany.

Clinical Pharmacology and Therapeutics
|September 30, 2020
PubMed
Summary

New algorithms for model selection and averaging improve drug exposure predictions for personalized dosing. These methods enhance accuracy and precision compared to single models, streamlining model-informed precision dosing (MIPD).

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.8K

Related Experiment Videos

Last Updated: Dec 7, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.2K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.8K

Area of Science:

  • Pharmacometrics
  • Clinical Pharmacology
  • Computational Biology

Background:

  • Drug variability impacts clinical outcomes and safety.
  • Pharmacometric models offer improved drug exposure forecasting over traditional monitoring.
  • Selecting the optimal model for model-informed precision dosing (MIPD) is a significant challenge.

Purpose of the Study:

  • To develop and evaluate a model selection algorithm (MSA) and a model averaging algorithm (MAA) for automated model selection in MIPD.
  • To implement MSA and MAA within the TDMx software for vancomycin therapy.
  • To compare the predictive performance of MSA and MAA against single-model approaches.

Main Methods:

  • Developed MSA and MAA to automate the selection or combination of pharmacometric models for individual patients.
  • Validated algorithms using a simulation study across six virtual populations.
  • Assessed predictive performance (accuracy and precision) on a clinical dataset of 180 vancomycin-treated patients.

Main Results:

  • MSA and MAA demonstrated superior predictive accuracy and precision in both simulation studies and the clinical dataset compared to single models.
  • In simulations, MSA/MAA achieved lower imprecision (9.9-24.2%) and inaccuracy (<±8.2%) versus single models (up to 51.1% imprecision, 28.9% inaccuracy).
  • In clinical data, MSA/MAA provided unbiased predictions (inaccuracy -5% to 0%) with improved precision (29-30%) compared to variable single-model performance (imprecision 28-62%, inaccuracy -16% to 25%).

Conclusions:

  • Automated model selection (MSA) and averaging (MAA) algorithms enhance the reliability of MIPD.
  • Implementation in TDMx software can simplify the validation process for individual patient models.
  • These approaches streamline MIPD, potentially improving therapeutic drug monitoring and patient outcomes.